Sales and Marketing

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …

Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …

Jack Goddard inve

A real-world evidence study, presented at the International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, has shown for the first …

Dermavant Sciences have presented successful data from two Phase III trials for tapinarof, for the treatment of psoriasis in adults, …

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion …

Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …

Phoenix Cardiac Devices have received CE Mark certification for its BACE (basal annuloplasty of the cardia externally) device, a novel …

The FDA have revoked Emergency Use Authorization (EUA) of Eli Lilly’s bamlanivimab drug for the treatment of COVID-19, per the …

NICE has unveiled its five-year plan to speed up patients’ access to the latest and most effective treatments with increased …

Sanofi has signed an exclusive worldwide licensing agreement with C4X Discovery Limited for C4XD’s oral pre-clinical IL-17A inhibitor programme, which …

The European Commission (EC) has approved a second indication of Sanofi’s Sarclisa drug for the treatment of adult patients with …

A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …

Sanofi have today announced a €400 million investment to create a unique vaccine production centre in Singapore, in partnership with …